A pharma CEO just jacked up the price of a 62-year-old drug by $736 a pill, and he's responding to critics on Twitter with Eminem quotes
Martin Shkreli, the hedge-fund-manager-turned-pharmaceutical-CEO, is in hot water after raising the price of the anti-parasite medication Daraprim from $13.50 a pill to $750.
Here's some more rap-related tweeting.
Despite his most recent emotion-fueled defensive tweets, the CEO occasionally gets serious. But it also looks like he has some good ideas about the direction pharmaceuticals should go, as far as transparency and new treatments are concerned.
NOW WATCH: More trouble for Subway's Jared Fogle...
- A 62-year-old drug just increased 55X in price — and now it's getting Hillary Clinton's attention
- 10 game-changing companies that are on track to revolutionize how we treat illness
- A US panel just backed the use of aspirin in preventing a type of cancer
CHECK OUT: 10 game-changing companies that are on track to revolutionize how we treat illness
More on AOL.com:
Republican candidate Carson 'absolutely' stands by comments on Muslims
It's Marco Rubio's Turn to Be the Savvy Pick for Front-Runner
'Fat Girl Running' blogger challenges stereotypes miles at a time